nivolumab 40 MG per 4 ML Injection
- RxCUI
- 1657190
- RxNorm name
- nivolumab 40 MG per 4 ML Injection
- Display name
- nivolumab 40 MG per 4 ML Injection
- Full name
- nivolumab 40 MG per 4 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125554 | Opdivo | nivolumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OPDIVO | NIVOLUMAB | E.R. Squibb & Sons, L.L.C. | f570b9c4-6846-4de2-abfa-4d0a4ae4e394 | 2026-05-12 | Warnings, Adverse reactions | 1657190 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f570b9c4-6846-4de2-abfa-4d0a4ae4e394 | nivolumab 40 MG in 4 ML Injection [PSN] · 4 ML nivolumab 10 MG/ML Injection [SCD] · nivolumab 40 MG per 4 ML Injection [SY] | 3 | 67 | These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO ® (nivolumab) injection, for intravenous use Initial U.S. Approval: 2014 | 20260512 |